Jane Wasman, President, International and GC at ACORDA THERAPEUTICS INC (ACOR), sold 3,750 shares at $31.89 ($119K) on 2015-10-05, disclosed to the SEC on 2015-10-06.
Scheduled sale ($119k) by President, International and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.91 | 531 | $16K | 13.8% |
| 2 | $31.89 | 3,219 | $103K | 86.2% |
| Total | $31.75 avg | 3,750 | $119K | 100% |
| Filing → |
| ACOR | SELL | 2018-12-06 | $126K | — | Filing → |
| ACOR | SELL | 2018-01-23 | $1.9M | — | Filing → |
| ACOR | SELL | 2017-12-05 | $187K | — | Filing → |